Abstract:Graphical and Lay Summary L‐asparaginases (EC 3.5.1.1) catalyze the conversion of L‐asparagine to L‐aspartic acid and ammonia. Although bacterial L‐asparaginases are commonly used in leukemia treatment, their immunogenicity has necessitated the exploration of alternative sources. Yeast‐derived L‐asparaginases, such as Lachancea thermotolerans L‐asparaginase (LtASNase), present a potential strategy for reducing toxicity. In this study, the Lys99Ala mutant of LtASNase was generated through semi‐rational design, resulting in significantly enhanced activity. In vitro testing against leukemia cell lines demonstrated that the mutant enzyme exhibits antileukemic activity comparable to commercial bacterial enzymes. These findings highlight the potential of yeast‐derived L‐asparaginases for therapeutic development. L‐asparaginases (EC 3.5.1.1) are amidohydrolase enzymes that predominantly catalyze conversion of L‐asparagine to L‐aspartic acid and ammonia. In addition, some exhibit secondary L‐glutaminase activity. Escherichia coli and Erwinia chrysanthemi L‐asparaginases are widely used in the pharmaceutical industry to produce therapeutically important compounds. In the therapeutic use of enzymes, bacterial L‐asparaginases can trigger immune responses, leading to a high rate of adverse effects that diminish the effectiveness of the treatment. This situation has forced scientists to search for promising L‐asparaginases from new sources. Yeast L‐asparaginases could be useful in reducing toxicity and enhancing efficacy but they have been poorly studied to date. Here, we characterized the yeast Lachancea thermotolerans L‐asparaginase (LtASNase) purified by affinity chromatography. It has a specific activity of 313.8 U/mg and a high kcat value (312.4 s). We demonstrated through a semi‐rational design that the mutations of Lys99 show varying effects on catalytic activity, with the Lys99Ala mutant increasing specific activity 3.3‐fold. Furthermore, the in vitro antileukemic activity of the non‐formulated form of Lys99Ala LtASNase was evaluated against SUP‐B15 and REH cell lines. The results demonstrated that LtASNase exhibits significant antileukemic potential, comparable to commercial type II bacterial enzymes. The understanding of the mutant L‐asparaginases examined in this study will significantly contribute to the development of new and more effective yeast‐derived asparaginases.

In Silico-Driven Engineering of Halomonas elongata L-Asparaginase: Towards Enhanced Proteolytic Resistance in Lymphoblastic Leukemia

The Improved Antineoplastic Activity of Thermophilic L-Asparaginase Tli10209 via Site-Directed Mutagenesis

Improving Toxicological, Immune and Inflammatory Responses

Homology modeling and molecular docking studies to decrease glutamine affinity of Yarrowia lipolytica L-asparaginase

Heterologous Expression and Rational Design of l-asparaginase from Rhizomucor miehei to Improve Thermostability

Production of highly cytotoxic and low immunogenic L-asparaginase from Stenotrophomonas maltophilia EMCC2297

Engineering Tk1656, a highly active l-asparaginase from Thermococcus kodakarensis, for enhanced activity and stability

Expression, characterization and cytotoxicity of recombinant l-asparaginase II from Salmonella paratyphi cloned in Escherichia coli

Thermostability enhancement and insight of L-asparaginase from Mycobacterium sp. via consensus-guided engineering

L‐Asparaginase from Lachancea Thermotolerans: Effect of Lys99Ala on Enzyme Performance and in vitro Antileukemic Efficacy

Thermostability Improvement of L-Asparaginase from Acinetobacter soli via Consensus-Designed Cysteine Residue Substitution

Isolation of asparaginase-producing microorganisms and evaluation of the enzymatic antitumor activity

A Structural In Silico Analysis of the Immunogenicity of L-Asparaginase from Penicillium cerradense

In vitro and in silico analysis unravelled clinically desirable attributes of Bacillus altitudinis L-asparaginase

Selecting and expressing protective single-chain Fv fragment to stabilize L-asparaginase against inactivation by trypsin

Engineering of Isoamylase: Improvement of Protein Stability and Catalytic Efficiency Through Semi-Rational Design

Production of a Novel Marine Pseudomonas aeruginosa Recombinant L-Asparaginase: Insight on the Structure and Biochemical Characterization

[Deletion of a Dynamic Surface Loop Improves Thermostability of (R)-Selective Amine Transaminase from Aspergillus Terreus].

Structures of L-Asparaginase from Bacillus Licheniformis Reveal an Essential Residue for Its Substrate Stereoselectivity.

L-Asparaginase Conjugates from the Hyperthermophilic Archaea Thermococcus sibiricus with Improved Biocatalytic Properties

Assessment of structural behaviour of a new L-asparaginase and SAXS data-based evidence for catalytic activity in its monomeric form